Cargando…
miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
In the present study, we investigated the role of miR-122 in hepatocarcinoma progression and explored the mechanism. In hepatocarcinoma tissues and cells, we used qRT-PCR to validate the miR-122 expression level. Next, we used colony formation by crystal violet staining assay to compare cell prolife...
Autores principales: | Li, Xiao-Na, Yang, Hong, Yang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851573/ https://www.ncbi.nlm.nih.gov/pubmed/31558184 http://dx.doi.org/10.3727/096504019X15615433287579 |
Ejemplares similares
-
MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R
por: Wang, Biyun, et al.
Publicado: (2012) -
MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarker
por: Wu, Weizhong, et al.
Publicado: (2017) -
CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR‐140‐5p/LMNB1 axis
por: Fu, Wen, et al.
Publicado: (2023) -
MiR-122 Promotes the Development of Colon Cancer by Targeting
ALDOA In Vitro
por: Li, Hong, et al.
Publicado: (2019) -
Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
por: Israelow, Benjamin, et al.
Publicado: (2014)